相关实验视频
Updated: Jul 17, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
188
在免疫检查点抑制剂诱导的炎症性关节炎中,疾病严重性的基线预测因素
Laura C Cappelli1, Omer Kamal2, Michelle Jones1
1Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Rheumatology (Oxford, England)
|August 30, 2023
概括
在免疫检查点抑制剂诱导的炎症性关节炎中需要免疫抑制的危险因素包括高疾病活性和紧突炎. 之前的化疗可能会减少对免疫抑制的需要,而组合治疗会增加持续性风险.
科学领域:
- 类风湿病学 类风湿病学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 可以诱导炎症性关节炎.
- 了解严重ICI诱导炎症性关节炎的风险因素对于患者管理至关重要.
研究的目的:
- 在ICI诱导的炎症性关节炎患者中确定需要免疫抑制和持久性关节炎的基线风险因素.
主要方法:
- 对126名患有风湿学家诊断的ICI炎性关节炎的成年患者进行了回顾性分析.
- 后勤回归模型评估了临床特征和结果之间的关联 (DMARD要求,关节炎持续时间>6个月,皮质类固醇使用).
主要成果:
- 42%的患者需要传统的合成 (cs) 或生物 (b) DMARDs.
- 较高的疾病活性 (CDAI),紧突炎和较长的症状持续时间与DMARD需求有关.
- 之前的化疗与需要DMARDs的可能性较低有关.
- 联合抗CTLA-4/PD-1治疗和基线皮质类固醇使用增加了持久性关节炎的风险.
结论:
- 高度的疾病活性,紧突炎和延迟的风湿病学转诊与ICI关节炎患者的免疫抑制需求增加有关.
- 之前的化疗可能有助于预防严重的ICI关节炎.
- 使用更高剂量的皮质类固醇或高级免疫抑制的早期干预可以改善结果.
更多相关视频
相关概念视频
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Inflammatory Bowel Disease II: Crohn's Disease
285
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
285
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173

